These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7478429)

  • 1. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors.
    Nagai MA; Medeiros AC; Brentani MM; Brentani RR; Marques LA; Mazoyer S; Mulligan LM
    Oncology; 1995; 52(6):448-53. PubMed ID: 7478429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours.
    Nagai MA; Yamamoto L; Salaorni S; Pacheco MM; Brentani MM; Barbosa EM; Brentani RR; Mazoyer S; Smith SA; Ponder BA
    Genes Chromosomes Cancer; 1994 Sep; 11(1):58-62. PubMed ID: 7529047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
    Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
    Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.
    Cropp CS; Champeme MH; Lidereau R; Callahan R
    Cancer Res; 1993 Dec; 53(23):5617-9. PubMed ID: 8242614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability and loss of heterozygosity in primary breast tumours.
    Sourvinos G; Kiaris H; Tsikkinis A; Vassilaros S; Spandidos DA
    Tumour Biol; 1997; 18(3):157-66. PubMed ID: 9143412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
    Johannsdottir HK; Jonsson G; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Heikkila P; Egilsson V; Olsson H; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
    Int J Cancer; 2006 Sep; 119(5):1052-60. PubMed ID: 16570289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer.
    Kirchweger R; Zeillinger R; Schneeberger C; Speiser P; Louason G; Theillet C
    Int J Cancer; 1994 Jan; 56(2):193-9. PubMed ID: 8314300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters.
    Dahiya R; Perinchery G; Deng G; Lee C
    Int J Oncol; 1998 Apr; 12(4):811-6. PubMed ID: 9499440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
    Cornelis RS; Devilee P; van Vliet M; Kuipers-Dijkshoorn N; Kersenmaeker A; Bardoel A; Khan PM; Cornelisse CJ
    Oncogene; 1993 Mar; 8(3):781-5. PubMed ID: 8437862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
    Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.
    Futreal PA; Söderkvist P; Marks JR; Iglehart JD; Cochran C; Barrett JC; Wiseman RW
    Cancer Res; 1992 May; 52(9):2624-7. PubMed ID: 1568230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublocalization of smallest common regions of deletion on chromosome 17q12-q23 in sporadic primary breast-tumors.
    Champeme M; Mazoyer S; Stoppalyonnet D; Bieche I; Ithier G; Sobol H; Nogues C; Lidereau R
    Oncol Rep; 1995 Sep; 2(5):825-31. PubMed ID: 21597825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
    Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
    Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumors.
    Callahan R; Cropp C; Sheng ZM; Merlo G; Steeg P; Liscia D; Lidereau R
    J Cell Biochem Suppl; 1993; 17G():167-72. PubMed ID: 8007695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.
    Kerangueven F; Eisinger F; Noguchi T; Allione F; Wargniez V; Eng C; Padberg G; Theillet C; Jacquemier J; Longy M; Sobol H; Birnbaum D
    Oncogene; 1997 Jan; 14(3):339-47. PubMed ID: 9018120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
    Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
    Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.